Cargando…

Factors not considered in the study of drug‐resistant epilepsy: Drug‐resistant epilepsy: Assessment of neuroinflammation

More than one‐third of people with epilepsy develop drug‐resistant epilepsy (DRE). Different hypotheses have been proposed to explain the origin of DRE. Accumulating evidence suggests the contribution of neuroinflammation, modifications in the integrity of the blood‐brain barrier (BBB), and altered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campos‐Bedolla, Patricia, Feria‐Romero, Iris, Orozco‐Suárez, Sandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Critical Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9340302/ https://www.ncbi.nlm.nih.gov/pubmed/35247028 http://dx.doi.org/10.1002/epi4.12590

Ejemplares similares

Factors not considered in the study of drug‐resistant epilepsy: Psychiatric comorbidities, age, and gender
por: Medel‐Matus, Jesús Servando, et al.
Publicado: (2022)

The gut microbiome in drug‐resistant epilepsy
por: Chatzikonstantinou, Simela, et al.
Publicado: (2021)

Drug‐resistant epilepsy: Drug target hypothesis and beyond the receptors
por: Fonseca‐Barriendos, Daniel, et al.
Publicado: (2021)

Drug resistance in idiopathic generalized epilepsies: Evidence and concepts
por: Gesche, Joanna, et al.
Publicado: (2022)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020)

Introduction to the special issue “Redesigning the hypotheses for drug‐resistant epilepsy”
por: Rocha, Luisa
Publicado: (2022)

Drug‐resistant epilepsy and mortality—Why and when do neuromodulation and epilepsy surgery reduce overall mortality
por: Rheims, Sylvain, et al.
Publicado: (2022)

Drug‐resistant epilepsy and the hypothesis of intrinsic severity: What about the high‐frequency oscillations?
por: Santana‐Gomez, Cesar E., et al.
Publicado: (2021)

The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug‐resistant epilepsy
por: Vázquez, Marta, et al.
Publicado: (2021)

Mechanisms of Drug Resistance in the Pathogenesis of Epilepsy: Role of Neuroinflammation. A Literature Review
por: Bazhanova, Elena D., et al.
Publicado: (2021)

Neuromodulation in Drug Resistant Epilepsy
por: Rincon, Natalia, et al.
Publicado: (2021)

Antiepileptic Drug Therapy in Patients with Drug-Resistant Epilepsy
por: Park, Kang Min, et al.
Publicado: (2019)

Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsy
por: Perucca, Emilio, et al.
Publicado: (2016)

Drug-Resistant Epilepsy and Surgery
por: Sheng, Jiyao, et al.
Publicado: (2018)

Managing drug-resistant epilepsy: challenges and solutions
por: Dalic, Linda, et al.
Publicado: (2016)

Diagnosis and Surgical Treatment of Drug-Resistant Epilepsy
por: Anyanwu, Chinekwu, et al.
Publicado: (2018)

Pharmacogenetics of Drug-Resistant Epilepsy (Review of Literature)
por: Smolarz, Beata, et al.
Publicado: (2021)

Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy
por: Galanopoulou, Aristea S., et al.
Publicado: (2016)

Governance of the clinical pathway and management of the patient suffering from epilepsy and drug-resistant epilepsy
por: La Neve, Angela, et al.
Publicado: (2022)

Disentangling the Gordian Knot of Drug-Resistant Epilepsy
por: Karakis, Ioannis
Publicado: (2021)

Multimodal neuroimaging in presurgical evaluation of drug-resistant epilepsy()
por: Zhang, Jing, et al.
Publicado: (2013)

Surgery for drug-resistant focal epilepsy
por: Rao, Malla Bhaskara, et al.
Publicado: (2014)

Causes and Risk Factors of Drug-Resistant Epilepsy in Children
por: NASIRI, Jafar, et al.
Publicado: (2023)

Drug-Resistant Juvenile Myoclonic Epilepsy: Misdiagnosis of Progressive Myoclonus Epilepsy
por: Martin, Sarah, et al.
Publicado: (2019)

Health Technology Assessment Report on Vagus Nerve Stimulation in Drug-Resistant Epilepsy
por: Marras, Carlo Efisio, et al.
Publicado: (2020)

Potential surgical therapies for drug‐resistant focal epilepsy
por: Shan, Wei, et al.
Publicado: (2021)

Neurostimulation as a Putative Method for the Treatment of Drug-resistant Epilepsy in Patient and Animal Models of Epilepsy
por: Bakhtiarzadeh, Fatemeh, et al.
Publicado: (2023)

Relationship between Neuroglial Apoptosis and Neuroinflammation in the Epileptic Focus of the Brain and in the Blood of Patients with Drug-Resistant Epilepsy
por: Sokolova, Tatiana V., et al.
Publicado: (2022)

Deep Brain Stimulation and Drug-Resistant Epilepsy: A Review of the Literature
por: Zangiabadi, Nasser, et al.
Publicado: (2019)

Prevalence and Incidence of Drug-Resistant Temporal Lobe Epilepsy in Qatar
por: Mesraoua, Boulenouar, et al.
Publicado: (2020)

The Utility of Responsive Neurostimulation for the Treatment of Pediatric Drug-Resistant Epilepsy
por: Piazza, Martin G., et al.
Publicado: (2023)

Syncope and Epilepsy coexist in ‘possible’ and ‘drug-resistant’ epilepsy (Overlap between Epilepsy and Syncope Study - OESYS)
por: Ungar, Andrea, et al.
Publicado: (2017)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Hemispherotomy for drug-resistant epilepsy in an Indonesian population
por: Arifin, Muhamad Thohar, et al.
Publicado: (2019)

Network radiofrequency ablation for drug resistant epilepsy
por: Shamim, Daniah, et al.
Publicado: (2021)

Clinical predictors of drug-resistant epilepsy in children
por: KARAOĞLU, Pakize, et al.
Publicado: (2021)

Disparities in pediatric drug-resistant epilepsy care
por: LoPresti, Melissa A., et al.
Publicado: (2023)

The right and the wrong with epilepsy and her science
por: Shorvon, Simon, et al.
Publicado: (2016)

Epilepsy in Morocco: Realities, pitfalls and prospects
por: Kissani, Najib, et al.
Publicado: (2020)

Status of epilepsy in the tropics: An overlooked perspective
por: Liu, Jiaqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d8g97d4nmug644rnj686e7po5k